Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,528 | -60,345 | -44,523 | -27,703 | -13,773 |
| Depreciation Amortization | -584 | 1,113 | 1,446 | 1,220 | 891 |
| Income taxes - deferred | 32 | 392 | 39 | 25 | 21 |
| Accounts payable and accrued liabilities | 1,324 | -722 | -251 | -1,115 | -410 |
| Other Working Capital | 3,760 | -1,037 | -2,941 | -3,399 | -3,183 |
| Other Operating Activity | 2,614 | 11,490 | 8,332 | 6,510 | 3,154 |
| Operating Cash Flow | $-14,382 | $-49,109 | $-37,898 | $-24,462 | $-13,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27,931 | -21,997 | -7,485 | -6,237 | 9,730 |
| PPE Investments | N/A | -275 | -241 | -249 | -242 |
| Investing Cash Flow | $27,931 | $-22,272 | $-7,726 | $-6,486 | $9,488 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,924 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 167,496 | 61,269 | 124 | N/A |
| Other Financing Activity | -344 | -401 | -144 | 0 | 0 |
| Financing Cash Flow | $27,580 | $167,095 | $61,125 | $124 | $N/A |
| Exchange Rate Effect | -10 | -178 | -223 | -69 | -8 |
| Beginning Cash Position | 143,235 | 47,699 | 47,699 | 47,699 | 47,699 |
| End Cash Position | 184,354 | 143,235 | 62,977 | 16,806 | 43,879 |
| Net Cash Flow | $41,119 | $95,536 | $15,278 | $-30,893 | $-3,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,382 | -49,109 | -37,898 | -24,462 | -13,300 |
| Capital Expenditure | N/A | -275 | -241 | -249 | -242 |
| Free Cash Flow | -14,382 | -49,384 | -38,139 | -24,711 | -13,542 |